LEADING

📅 Upcoming

🕒 Recent(90d)

News

• Opinion: How Congress can fix expert advisory committees
  “This evisceration of scientific advice is untenable,” write C. Joseph Ross Daval and Aaron S. Kesselheim.
  stat · 3h ago
• Dren Bio lands $350M to push rare blood cancer therapy toward market
  After Sanofi paid $600 million in cash to acquire Dren Bio’s bispecific last year, the biotech has secured a hefty financing to fund late-stage development and commercial preparations for its lead…
  biospace · 17h ago
• Lilly’s guidance has jumped by $10B as GLP-1 sales keep blowing past expectations
  With the commercial business performing so well, Eli Lilly is eyeing earlier business development bets to build out a longer-term pipeline.
  biospace · 19h ago
• LENZ cuts 75% of staff as third quarter earnings disappoint
  Follow along as BioSpace tracks job cuts and restructuring initiatives.
  biospace · 22h ago
• Ono cans 2 endocannabinoid drug studies after quintuple Phase 2 failure
  Ono Pharma’s ONO-1110 failed five Phase 2 trials, leading to the discontinuation of development in depression and social anxiety. Work will continue for three pain indications.
  biospace · 22h ago
• Merck outlines 2027 as ‘another year of investment’ despite recent clinical wins
  Even as a wave of clinical trial wins bolsters its momentum, Merck & Co. is prioritizing ongoing pipeline and commercial expansions over near-term margin growth, hoping to strengthen its long-term…
  fiercebiotech · 1d ago
• STAT+: Biopharma industry at odds over impact of Treasury’s new China rule
  An exemption for a common kind of biopharma deal is at the heart of disagreements over the proposal.
  stat · 1d ago
• Politicians have failed to tackle health care affordability. It’s now voters’ rallying cry
  As costs surge, voters are embracing more radical solutions to the crisis.
  stat · 1d ago
• Biopharma cuts at manufacturing plants expected to affect 4,000+
  As companies invest billions of dollars to reshore manufacturing, 10 biotech and pharma businesses are reportedly trimming staff at manufacturing locations in 2026 or the coming years, with BioNTec…
  biospace · 1d ago
• Early Alert: Medline Removes or Corrects All Medline Brand Beds and Accessories
  Medline removes or corrects all brand beds & accessories due to fire, electrical overheating, entrapment & asphyxiation risks. Risk of serious injury or death.
  fda_medwatch · 1d ago